mci 9038 has been researched along with Syndrome in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (29.41) | 18.2507 |
2000's | 10 (58.82) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ito, S; McAlister, RK | 1 |
Chakraborty, AK; Griffin, DK; Sheppard, JA; Warkentin, TE | 1 |
Aizawa, Y; Fuse, I; Hanzawa, K; Hayashi, J; Higuchi, K; Hori, T; Matsubara, T; Mezaki, T; Moro, H; Nasuno, A; Tanaka, K; Tanaka, T; Tsuchida, K | 1 |
Higuma, N; Honsako, A; Miida, T; Oda, H; Sakai, K; Takahashi, K | 1 |
Lincoff, AM | 1 |
Call, JT; Deliargyris, EN; Sane, DC | 1 |
Bhatt, DL; Gurm, HS | 1 |
Cooney, MF | 1 |
Jolicoeur, EM; Lopes, RD; Ohman, EM; Wang, T | 1 |
Lepor, NE | 1 |
Akiguchi, I; Kaji, R; Kanda, M; Murase, N; Satoi, H | 1 |
Donkin, J; Iaffaldano, R; Lewis, BE; McKiernan, TL; Rao, L; Wallenga, JM | 1 |
Lewis, BE; Walenga, JM; Wallis, DE | 1 |
Fareed, J; Lewis, BE; Rangel, Y | 1 |
Ahmad, S; Callas, D; Fareed, J; Haas, S; Hoppensteadt, DA; Jeske, WP; Lietz, H; Messmore, HL; Walenga, JM | 1 |
White, HD; Wong, CK | 1 |
Fleischer, K; Gulba, DC; Lankes, W | 1 |
10 review(s) available for mci 9038 and Syndrome
Article | Year |
---|---|
Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
Topics: Angioplasty, Balloon, Coronary; Arginine; Clinical Trials as Topic; Coronary Disease; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thrombolytic Therapy | 2003 |
Direct thrombin inhibitors in the treatment of immune-mediated heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Binding Sites; Heparin; Hirudins; Humans; Models, Biological; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thrombocytopenia; Treatment Outcome | 2004 |
Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Coronary Disease; Heparin; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis | 2005 |
Heparin-induced thrombocytopenia: advances in diagnosis and treatment.
Topics: Administration, Oral; Anticoagulants; Arginine; Critical Care; Drug Monitoring; Enzyme-Linked Immunosorbent Assay; Heparin; Hirudins; Humans; International Normalized Ratio; Nurse's Role; Nursing Assessment; Partial Thromboplastin Time; Patient Selection; Pipecolic Acids; Platelet Count; Practice Guidelines as Topic; Recombinant Proteins; Risk Factors; Sulfonamides; Syndrome; Thrombocytopenia; Time Factors | 2006 |
Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
Topics: Algorithms; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Chondroitin Sulfates; Comorbidity; Dermatan Sulfate; Drug Therapy, Combination; Fibrinolytic Agents; Fondaparinux; Heparin; Heparinoids; Heparitin Sulfate; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Syndrome; Thrombocytopenia; Vitamin K | 2007 |
Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Fondaparinux; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Models, Molecular; Molecular Structure; Myocardial Ischemia; Peptide Fragments; Pipecolic Acids; Platelet Activation; Polysaccharides; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thrombosis | 2007 |
Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Antibodies; Antithrombins; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis | 1997 |
Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulation.
Topics: Anticoagulants; Antithrombins; Arginine; Hemostasis; Heparin; Humans; Models, Biological; Pipecolic Acids; Selectins; Sulfonamides; Syndrome; Thrombocytopenia | 1999 |
Medical treatment for acute coronary syndromes.
Topics: Angina, Unstable; Arginine; Coronary Angiography; Fibrinolytic Agents; Heparin; Humans; Metalloendopeptidases; Myocardial Infarction; Pipecolic Acids; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sulfonamides; Survival Rate; Syndrome; Thrombolytic Therapy; Tissue Plasminogen Activator | 2000 |
[Direct thrombin antagonists].
Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Antithrombins; Arginine; Azetidines; Benzylamines; Fibrinolytic Agents; Glycine; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Rabbits; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Time Factors | 2001 |
7 other study(ies) available for mci 9038 and Syndrome
Article | Year |
---|---|
Minimal Prolongation of Prothrombin Time with Extended Exposure to Argatroban.
Topics: Anticoagulants; Antithrombins; Arginine; Carcinoma, Squamous Cell; Drug Substitution; Female; Heparin; Humans; International Normalized Ratio; Mandibular Neoplasms; Middle Aged; Mouth Mucosa; Pipecolic Acids; Prothrombin Time; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis; Treatment Failure; Warfarin | 2015 |
The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome.
Topics: Aged; Arginine; Female; Fondaparinux; Heparin; Humans; Immunoenzyme Techniques; Inflammation; Pipecolic Acids; Platelet Factor 4; Polysaccharides; Sulfonamides; Syndrome; Thrombocytopenia; Treatment Outcome | 2012 |
Acute pulmonary thromboembolism induced by prophylactic heparin use and a heparin-coated catheter: a case of heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Acute Disease; Anticoagulants; Arginine; Catheterization; Catheterization, Central Venous; Coated Materials, Biocompatible; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Radionuclide Imaging; Sulfonamides; Syndrome; Thrombocytopenia; Thromboembolism; Tomography, X-Ray Computed; Ultrasonography | 2003 |
Obstinate thrombosis during percutaneous coronary intervention in a case with heparin-induced thrombocytopenia with thrombosis syndrome successfully treated by argatroban anticoagulant therapy.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Cardiac Catheterization; Coronary Stenosis; Coronary Thrombosis; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Pipecolic Acids; Radiography; Risk Assessment; Sulfonamides; Syndrome; Thrombocytopenia; Treatment Outcome | 2003 |
[Familial Binswanger-type encephalopathy with Sneddon syndrome].
Topics: Adult; Antithrombin III; Antithrombins; Arginine; Cerebral Infarction; Dementia; Factor V; Female; Fibrinogen; Humans; Male; Migraine Disorders; Peptide Hydrolases; Pipecolic Acids; Sneddon Syndrome; Sulfonamides; Syndrome | 1996 |
Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Coronary Angiography; Coronary Disease; Female; Heparin; Humans; Myocardial Infarction; Pipecolic Acids; Platelet Aggregation Inhibitors; Stents; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis | 1996 |
The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Carotid Arteries; Carotid Stenosis; Catheterization; Cerebrovascular Disorders; Femoral Artery; Follow-Up Studies; Heparin; Humans; Male; Paresis; Pipecolic Acids; Platelet Aggregation Inhibitors; Recurrence; Stents; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis | 1998 |